Skip to content

Insider · CIK 0001782815

Frank Stokes

cfoofficerdirector

Files at XGN (EXAGEN INC.), CSTL (CASTLE BIOSCIENCES INC). First filing Nov 19, 2024, latest Mar 9, 2026.

Frank Stokes files SEC Form 4 as CFO and director at CSTL (CASTLE BIOSCIENCES INC), and also at XGN (EXAGEN INC.). Since Nov 19, 2024, Frank Stokes has reported 0 open-market buys worth $0 and 6 open-market sells worth $1.1M, the latest filed on Mar 9, 2026.

A track record needs three past buys with six months of prices behind them; Frank Stokes has 0, so none is measured yet.

The newest scored trade: sold $168k of CSTL on Mar 5, 2026, filed Mar 9, 2026, scored 28 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $717k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $1.1M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CSTL: CASTLE BIOSCIENCES INC

CSTLOct 9, 2026 · close 34.42

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
28Weak
CSTLsell 410b5-1
CASTLE BIOSCIENCES INC
$168k
6,001 shares
-9%+91% from low-35% from high
19Weak
CSTLsell 410b5-1
CASTLE BIOSCIENCES INC
$192k
7,000 shares
-12%+88% from low-36% from high
48Moderate
CSTLsell 4
CASTLE BIOSCIENCES INC
$168k
4,496 shares
-8%+159% from low-5% from high
34Weak
CSTLsell 410b5-1
CASTLE BIOSCIENCES INC
$189k
5,388 shares
-11%+139% from low0% from high
27Weak
CSTLsell 210b5-1
CASTLE BIOSCIENCES INC
$215k
8,046 shares
-19%-
34Weak
CSTLsell 410b5-1
CASTLE BIOSCIENCES INC
$207k
6,923 shares
-18%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Mar 5, 2026 CSTL
CASTLE BIOSCIENCES, INC.
6,001
0.02% of outstanding
$169kMar 5, 2026$360k
Mar 3, 2026 CSTL
CASTLE BIOSCIENCES INC
7,000
0.02% of outstanding
$196kMar 3, 2026$168k
Dec 11, 2025 CSTL
CASTLE BIOSCIENCES, INC.
4,496
0.02% of outstanding
$168kDec 11, 2025$189k
Nov 12, 2025 CSTL
CASTLE BIOSCIENCES INC
5,388
0.02% of outstanding
$187kNov 11, 2025none
Nov 14, 2024 CSTL
CASTLE BIOSCIENCES INC
6,923
0.02% of outstanding
$218kNov 15, 2024$257k

Transactions

Every row this insider has filed, 42 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 9, 2026XGN
EXAGEN INC.
AGrant or award
Stock Option(right to buy)derivative
+37,500$0.00$0112,500Jun 22, 2026
Mar 5, 2026CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-6,001$27.98$168k60,085Mar 9, 2026
Mar 3, 2026CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-5,300$27.32$145k54,183Mar 5, 2026
Mar 3, 2026CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-1,700$27.81$47k52,483Mar 5, 2026
Mar 3, 2026CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock10b5-1
-3,611$27.57$100k48,872Mar 5, 2026
Mar 4, 2026CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+24,146--73,018Mar 5, 2026
Mar 4, 2026CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock10b5-1
-10,732$28.17$302k62,286Mar 5, 2026
Mar 4, 2026CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+3,800$3.38$13k66,086Mar 5, 2026
Mar 3, 2026CSTL
CASTLE BIOSCIENCES INC
AGrant or award
Restricted Stock Unitsderivative10b5-1
+48,367$0.00$048,367Mar 5, 2026
Mar 4, 2026CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-12,186$0.00$024,372Mar 5, 2026
Mar 4, 2026CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-11,960$0.00$035,878Mar 5, 2026
Mar 4, 2026CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Stock option (right to buy)derivative10b5-1
-3,800$0.00$014,912Mar 5, 2026
Jan 12, 2026CSTL
CASTLE BIOSCIENCES INC
AGrant or award
Common Stock
+8,124$0.00$058,450Jan 14, 2026
Jan 12, 2026CSTL
CASTLE BIOSCIENCES INC
AGrant or award
Performance-Based Stock Unitderivative
+8,124$0.00$08,124Jan 14, 2026
Dec 11, 2025CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock
-4,496$37.45$168k50,326Dec 15, 2025
Dec 9, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+14,616--57,944Dec 11, 2025
Dec 9, 2025CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-6,534$38.25$250k51,410Dec 11, 2025
Dec 10, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+6,170--57,580Dec 11, 2025
Dec 10, 2025CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-2,758$38.02$105k54,822Dec 11, 2025
Dec 9, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative
-14,616$0.00$014,617Dec 11, 2025
Dec 10, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative
-6,170$0.00$00Dec 11, 2025
Nov 11, 2025CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-5,388$35.08$189k43,328Nov 13, 2025
Aug 8, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+9,744$0.00$053,072Aug 12, 2025
Aug 8, 2025CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-4,356$19.36$84k48,716Aug 12, 2025
Aug 8, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Performance-Based Stock Unitderivative
-9,744$0.00$00Aug 12, 2025
Jun 10, 2025XGN
EXAGEN INC.
AGrant or award
Stock Option(right to buy)derivative
+9,000$0.00$09,000Jun 12, 2025
Mar 4, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+12,186--48,776Mar 6, 2025
Mar 4, 2025CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-5,448$22.23$121k43,328Mar 6, 2025
Mar 4, 2025CSTL
CASTLE BIOSCIENCES INC
AGrant or award
Restricted Stock Unitsderivative
+47,838$0.00$047,838Mar 6, 2025
Mar 4, 2025CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative
-12,186$0.00$036,558Mar 6, 2025
Feb 20, 2025CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-8,046$26.70$215k35,319Feb 24, 2025
Dec 9, 2024CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+14,617--45,440Dec 11, 2024
Dec 9, 2024CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-6,571$30.91$203k38,869Dec 11, 2024
Dec 10, 2024CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+2,000--40,869Dec 11, 2024
Dec 10, 2024CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-900$29.63$27k39,969Dec 11, 2024
Dec 10, 2024CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Common Stock
+6,169--46,138Dec 11, 2024
Dec 10, 2024CSTL
CASTLE BIOSCIENCES INC
FTax withholding
Common Stock
-2,773$29.63$82k43,365Dec 11, 2024
Dec 9, 2024CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative
-14,617$0.00$029,233Dec 11, 2024
Dec 10, 2024CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative
-2,000$0.00$00Dec 11, 2024
Dec 10, 2024CSTL
CASTLE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative
-6,169$0.00$06,170Dec 11, 2024
Nov 15, 2024CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-6,123$29.87$183k31,623Nov 19, 2024
Nov 15, 2024CSTL
CASTLE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-800$30.40$24k30,823Nov 19, 2024

Questions about Frank Stokes

Answered from the filings on this page, as of the latest one.

Is Frank Stokes buying or selling?

In the last 12 months Frank Stokes reported 0 open-market buys worth $0 and 4 open-market sells worth $717k on SEC Form 4; the latest was sold $168k of CSTL on Mar 5, 2026. Grants, option exercises and tax withholding are not counted.

How did Frank Stokes's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Frank Stokes has 0.

Where does Frank Stokes file Form 4?

Frank Stokes has filed Form 4 at CSTL (CASTLE BIOSCIENCES INC) as Chief Financial Officer; XGN (EXAGEN INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.